Arbutus Biopharma Corp
For the period ended May 26, 2026. Filed Apr 14, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 26, 2026 · Filed Apr 14, 2026
ABUS$3.66-0.4%Stored close · as of Nov 6, 2026
Contents
APPROVAL OF MANAGEMENT PROXY CIRCULAR AND PROXY STATEMENT
The contents and mailing to Shareholders of this Proxy Statement/Circular have been approved by our Board.
Lindsay Androski, JD, MBA, CFA, Chairperson of the Board of Directors
April 14, 2026
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.